Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cerilliant
McKesson
Covington
Chinese Patent Office
Fish and Richardson
Citi
Baxter
Cantor Fitzgerald

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,422,123

« Back to Dashboard

Summary for Patent: 5,422,123
Title: Tablets with controlled-rate release of active substances
Abstract:Tablets with zero order controlled-rate of release of the active substances, consisting of a core of defined geometrical form containing the active substance, polymer substances which swell on contact with aqueous liquids and polymer substances with gelling properties, and a support applied to said core to partly cover its surface, the support consisting of polymer substances which are slowly soluble and/or slowly gellable in aqueous liquids, plasticizing substances, and possibly substances with an adjuvant function.
Inventor(s): Conte; Ubaldo (Busto Arsizio, IT), La Manna; Aldo (Pavia, IT), Colombo; Paolo (Pavia, IT)
Assignee: Jagotec AG (Hergiswil, CH)
Application Number:08/123,982
Patent Claim Types:
see list of patent claims
Composition; Process; Dosage form;

Drugs Protected by US Patent 5,422,123

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,422,123

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Italy22694/89Dec 14, 1989

International Family Members for US Patent 5,422,123

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 135906 ➤ Try a Free Trial
Canada 2031393 ➤ Try a Free Trial
Germany 69026215 ➤ Try a Free Trial
Denmark 0432607 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Accenture
AstraZeneca
Cantor Fitzgerald
Colorcon
Baxter
US Army
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.